Speaker illustration

Miss Marianne Frank Clausen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Risk of valvular heart disease in bromocriptine-treated women with hyperprolactinaemic disorders

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Implementing biomarkers for valvular heart disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb